Literature DB >> 11296214

Etiology of community-acquired pneumonia requiring hospitalization in Japan.

N Miyashita, H Fukano, Y Niki, T Matsushima, N Okimoto.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11296214     DOI： 10.1378/chest.119.4.1295-a

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  7 in total

1.  In vitro and in vivo activities of sitafloxacin against Chlamydia spp.

Authors:  N Miyashita; Y Niki; T Matsushima
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 2.  International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.

Authors:  Thomas M File; James S Tan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis.

Authors:  Takashi Hirama; Takefumi Yamaguchi; Hitoshi Miyazawa; Tomoaki Tanaka; Giichi Hashikita; Etsuko Kishi; Yoshimi Tachi; Shun Takahashi; Keiji Kodama; Hiroshi Egashira; Akemi Yokote; Kunihiko Kobayashi; Makoto Nagata; Toshiaki Ishii; Manabu Nemoto; Masahiko Tanaka; Koichi Fukunaga; Satoshi Morita; Minoru Kanazawa; Koichi Hagiwara
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 4.  Community-acquired pneumonia: an Asia Pacific perspective.

Authors:  Chong-Kin Liam; Yong-Kek Pang; Shyamala Poosparajah; Keong-Tiong Chua
Journal:  Respirology       Date:  2007-03       Impact factor: 6.424

Review 5.  Community-acquired pneumonia.

Authors:  Thomas M File
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

Review 6.  Community-Acquired Pneumonia in the Asia-Pacific Region.

Authors:  Jae-Hoon Song; Kyungmin Huh; Doo Ryeon Chung
Journal:  Semin Respir Crit Care Med       Date:  2016-12-13       Impact factor: 3.119

7.  Atypical pneumonia--time to breathe new life into a useful term?

Authors:  David R Murdoch; Stephen T Chambers
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.